Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2529-2532, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abell, C. W.
Right arrow Articles by Stith, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abell, C. W.
Right arrow Articles by Stith, W. J.

An in Vivo Evaluation of the Chemotherapeutic Potency of Phenylalanine Ammonia-Lyase1

C. W. Abell, D. S. Hodgins2 and W. J. Stith

Division of Biochemistry, Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch, Galveston, Texas 77550

Phenylalanine ammonia-lyase from yeast was evaluated for its chemotherapeutic effectiveness against the murine L5178Y lymphoblastic leukemia maintained in C57BL/6 x DBA/2 F1 (BD2F1) mice. This enzyme, administered at concentrations of 300 units/kg, rapidly lowered plasma phenylalanine and tyrosine levels, inhibited tumor growth, and produced cures in 40% of the mice. Partially purified preparations of this enzyme, coupled with diets containing low levels of phenylalanine, significantly increased the average life-span of the mice and also produced cures. These results suggest that phenylalanine ammonia-lyase may be a valuable new chemotherapeutic agent for the treatment of some neoplasms.

1 This study was supported in part by USPHS Research Grant CA-11732 from the National Cancer Institute.

2 On sabbatical leave from the University of Oklahoma Health Sciences Center, Oklahoma City, Okla. 73190.

Received 7/ 2/73. Accepted 8/ 7/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.